An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE-Reference-Cited by-同舟云学术

An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE

Published:2018-10-08 Issue:12 Volume:73 Page:2328-2341
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Josephs D. H.¹²,Nakamura M.¹,Bax H. J.¹²,Dodev T. S.³,Muirhead G.⁴,Saul L.¹²,Karagiannis P.¹²,Ilieva K. M.¹⁵,Crescioli S.¹,Gazinska P.⁵⁶,Woodman N.⁶,Lombardelli C.⁶,Kareemaghay S.⁶,Selkirk C.⁷,Lentfer H.⁷,Barton C.⁸,Canevari S.⁹,Figini M.⁹,Downes N.¹⁰,Dombrowicz D.¹¹,Corrigan C. J.¹²,Nestle F. O.¹¹³,Jones P. S.⁸,Gould H. J.³,Blower P. J.¹⁴,Tsoka S.⁴,Spicer J. F.²,Karagiannis S. N.¹⁵^ORCID

Affiliation:

1. St. John's Institute of Dermatology; School of Basic & Medical Biosciences; King's College London; London UK

2. School of Cancer & Pharmaceutical Sciences; Guy's Hospital; King's College London; London UK

3. Randall Centre for Cell and Molecular Biophysics; King's College London; London UK

4. Department of Informatics; Faculty of Natural and Mathematical Sciences; King's College London; London UK

5. Breast Cancer Now Research Unit; School of Cancer & Pharmaceutical Sciences; Guy's Cancer Centre; King's College London; London UK

6. King's Health Partners Cancer Biobank; School of Cancer & Pharmaceutical Sciences; King's College London; London UK

7. Biotherapeutics Development Unit; Cancer Research UK; South Mimms UK

8. Centre for Drug Development; Cancer Research UK; London UK

9. Department of Applied Research and Technology Development; Fondazione IRCCS Istituto Nazionale dei Tumouri; Milan Italy

10. Sequani; Ledbury UK

11. CHU Lille; Institut Pasteur de Lille; Inserm; Univ. Lille; Lille France

12. Medical Research Council & Asthma UK Centre in Allergic Mechanisms of Asthma; King's College London; London UK

13. Immunology and Inflammation Therapeutic Research Area; Sanofi US; Cambridge MA USA

14. Imaging Chemistry & Biology; Division of Imaging Sciences and Biomedical Engineering; St. Thomas's Hospital; King's College London; London UK

Funder

Breast Cancer Now

CRUK/EPSRC/MRC/NIHR KCL/UCL Comprehensive Cancer Imaging Centre

Academy of Medical Sciences

Medical Research Council

Cancer Research UK

National Institute for Health Research

CRUK/NIHR in England/DoH for Scotland, Wales and Northern Ireland Experimental Cancer Medicine Centre

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/all.13455/fullpdf

Reference29 articles.

1. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412;Suntharalingam;N Engl J Med,2006

2. European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP) Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products 2017

3. Affinity of human IgG subclasses to mouse Fc gamma receptors;Dekkers;mAbs,2017

4. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology;Kinet;Annu Rev Immunol,1999

5. Molecular structure and expression of the murine lymphocyte low-affinity receptor for IgE (Fc epsilon RII);Bettler;Proc Natl Acad Sci USA,1989

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Monoclonal Antibodies against Cancer: Present and Future;Cells;2023-12-14

2. Роль микробиоты в канцерогенезе;Malignant tumours;2023-11-23

3. Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial;Nature Communications;2023-07-25

4. Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4;Nature Communications;2023-04-25

5. Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice;Allergy;2022-10-18